Smith & Nephew To Set Up Factory In Suzhou Industrial Park
This article was originally published in PharmAsia News
Executive Summary
Smith & Nephew recently held a groundbreaking ceremony for its first factory in China at the Suzhou Industrial Park. With an initial investment of $80 million, the plant will mainly produce medical devices that will be supplied to 65 countries across the world. Smith & Nephew officials said Suzhou Industrial Park was chosen because of its first-class environment and facilities as well as enterprising atmosphere. To date, the park has attracted health care MNCs such as GSK, Eli Lilly, Eisai, Baxter, Herbalife and Johnson & Johnson, with total investment surpassing $1 billion. (Click here for more - Chinese Language)